Showing results (361-370 of 398) with videos related to

Sort By:
Pageof 40
Journal of Clinical Biochemistry and Nutrition|January 12, 2008
Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDYSoo-Heon Park, Chul-Soo Cho, Oh-Young Lee, et al.
Nano-Micro Letters|September 20, 2024
Advanced Functional Electromagnetic Shielding Materials: A Review Based on Micro-Nano Structure Interface Control of Biomass Cell WallsYang Shi, Mingjun Wu, Shengbo Ge, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 8, 2011
[General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease]Min-de Zeng, Bing-yuan Wang, Cheng-wei Chen, et al.
European Radiology|March 19, 2021
AI detection of mild COVID-19 pneumonia from chest CT scansJin-Cao Yao, Tao Wang, Guang-Hua Hou, et al.
Emerging Microbes & Infections|November 7, 2023
Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trialJia-Wei Xu, Bu-Sen Wang, Ping Gao, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 21, 2017
Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled TrialJin-Hua Hou, Wei-Bo Le, Nan Chen, et al.
The Lancet. Global Health|December 27, 2016
Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trialJing-Xin Li, Li-Hua Hou, Fan-Yue Meng, et al.
Chinese Journal of Integrative Medicine|July 12, 2019
Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control TrialXu-Dong Tang, Sheng-Sheng Zhang, Xiao-Hua Hou, et al.
Journal of Digestive Diseases|July 27, 2020
Liver damage at admission is an independent prognostic factor for COVID-19Liu Ying Chen, Hui Kuan Chu, Tao Bai, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 23, 2020
The Diagnosis Performance of the TCM Syndromes of Irritable Bowel Syndrome by Gastroenterologists Based on Modified Simple Criteria Compared to TCM Practitioners: A Prospective, Multicenter Preliminary StudyJun Song, Ling Yang, Shuai Su, et al.
Pageof 40